论文部分内容阅读
作者自１９８６年１０月～１９９６年５月共手术治疗贲门癌并发大出血２８例，占同期手术治疗贲门癌的６．２２％（２８／４５０）。全组２８例术前出血量均在１０００ｍｌ以上，其中合并失血性休克８例。在手术治疗贲门癌大出血２８例中有７例行急诊手术。全组切除率１００％（２８／２８）。术后无吻合口瘘及其它并发症的发生。术后生存５年以上者３例（均健在），３年以上８例（５例健在），２年以上９例（均健在），１年以内８例（均健在）。作者认为：贲门癌大出血并非为肿瘤的晚期表现，积极手术治疗，其预后基本与一般贲门癌相同
From October 1986 to May 1996, the authors had a total of 28 cases of cardiac cancer complicated with massive bleeding, which accounted for 6.22% (28/450) of the surgical treatment of cardiac cancer at the same time. The total amount of preoperative blood loss in 28 patients was more than 1000 ml, including 8 cases of hemorrhagic shock. Among the 28 cases of surgical treatment of cardiac cancer hemorrhage, 7 cases underwent emergency surgery. The total resection rate was 100% (28/28). No anastomotic leakage and other complications occurred after surgery. There were 3 cases who survived more than 5 years after operation (all were alive), 8 cases were more than 3 years (5 cases were alive), 9 cases were more than 2 years (all were alive), and 8 cases were alive within 1 year. The author believes that: Cardiac cancer hemorrhage is not a late manifestation of the tumor, active surgical treatment, the prognosis is basically the same with general cardiac cancer